DCM
CRL icon

Dupont Capital Management’s Charles River Laboratories CRL Stock Holding History

Dupont Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,710
Closed -$360K – 299
2023
Q2 		$360K Sell
1,710
-170
-9% -$33.8K 0.02% 321
2023
Q1 		$379K Sell
1,880
-2,100
-53% -$476K 0.02% 368
2022
Q4 		$867K Sell
3,980
-586
-13% -$128K 0.04% 406
2022
Q3 		$899K Sell
4,566
-735
-14% -$159K 0.05% 444
2022
Q2 		$1.13M Buy
5,301
+1,072
+25% +$262K 0.05% 388
2022
Q1 		$1.2M Sell
4,229
-377
-8% -$116K 0.05% 412
2021
Q4 		$1.74M Sell
4,606
-1,541
-25% -$599K 0.06% 315
2021
Q3 		$2.54M Sell
6,147
-3,219
-34% -$1.34M 0.08% 260
2021
Q2 		$3.46M Buy
9,366
+1,863
+25% +$622K 0.08% 211
2021
Q1 		$2.17M Sell
7,503
-7,371
-50% -$2.05M 0.05% 309
2020
Q4 		$3.72M Sell
14,874
-1,490
-9% -$355K 0.08% 196
2020
Q3 		$3.71M Buy
16,364
+12,764
+355% +$2.65M 0.08% 188
2020
Q2 		$628K Sell
3,600
-996
-22% -$159K 0.01% 675
2020
Q1 		$580K Sell
4,596
-2,907
-39% -$436K 0.01% 621
2019
Q4 		$1.15M Buy
7,503
+569
+8% +$78.8K 0.03% 533
2019
Q3 		$918K Buy
6,934
+1,988
+40% +$267K 0.02% 550
2019
Q2 		$702K Hold
4,946
– – 0.02% 647
2019
Q1 		$718K Buy
4,946
+532
+12% +$69.9K 0.02% 633
2018
Q4 		$500K Sell
4,414
-4,009
-48% -$502K 0.01% 728
2018
Q3 		$1.13M Hold
8,423
– – 0.03% 533
2018
Q2 		$946K Buy
8,423
+4,921
+141% +$532K 0.02% 568
2018
Q1 		$374K Sell
3,502
-7,998
-70% -$862K 0.01% 725
2017
Q4 		$1.26M Buy
11,500
+2,577
+29% +$280K 0.03% 469
2017
Q3 		$964K Hold
8,923
– – 0.02% 526
2017
Q2 		$903K Sell
8,923
-1,998
-18% -$184K 0.02% 543
2017
Q1 		$982K Hold
10,921
– – 0.02% 529
2016
Q4 		$832K Buy
+10,921
New +$829K 0.02% 541

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dupont Capital Management's CRL Position: Q3 2023 in Review

Dupont Capital Management sold out of Charles River Laboratories (CRL) in Q3 2023, closing a stake of 1,710 shares — an estimated $360K sold.

Dupont Capital Management first reported a position in CRL in Q4 2016 and held it in 27 quarters. The position peaked at $3.72M in Q4 2020. 621 funds tracked by Wall St. Rank hold CRL as of Q3 2023.

  • Dupont Capital Management reported no remaining Charles River Laboratories position as of Q3 2023 after selling out during the quarter.
  • Dupont Capital Management sold 1,710 Charles River Laboratories shares in Q3 2023, an estimated $360K.
  • Dupont Capital Management first reported a position in Charles River Laboratories in Q4 2016 and held it in 27 quarters.
  • Dupont Capital Management's Charles River Laboratories position peaked at $3.72M in Q4 2020.
  • 621 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2023.

Based on Dupont Capital Management's 13F filing for Q3 2023, filed 27 Oct 2023.